Overview

The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the the study is to investigate the changes in bone remodeling during Velcade treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Vejle Hospital
Collaborator:
Odense University Hospital
Treatments:
Bortezomib